Suppr超能文献

新冠病毒是否会为毛霉菌病的传播创造环境?

Does COVID 19 generate a milieu for propagation of mucormycosis?

机构信息

Department of Oral Pathology and Microbiology, Saveetha Dental College and Hospitals, Chennai, Tamil Nadu, India; Department of Oral Pathology and Microbiology, Postgraduate Institute of Dental Sciences, Rohtak, Haryana, India.

Department of Oral Pathology and Microbiology, Postgraduate Institute of Dental Sciences, Rohtak, Haryana, India.

出版信息

Med Hypotheses. 2021 Jul;152:110613. doi: 10.1016/j.mehy.2021.110613. Epub 2021 May 26.

Abstract

Corona Virus Disease 2019 (COVID 2019), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a dreadful infectious disease which has emerged as one of the most significant medical emergency affecting everyone directly or indirectly. COVID 2019 is a multisystem disease and causes severe immunosuppression. Initially thought to affect mainly the respiratory system, it strikes all vital organ systems and cause defects in cardio-circulatory, respiratory system and gastrointestinal systems to name a few leading to copious biochemical alterations. Reports show there is thromoembolism, raised ferritin levels, lymphocytopenia, thrombocytopenia, lactic acidosis, acute diabetes like state and cytokine storm. Data regarding levels of neutrophils is equivocal. Further there is increased incidence regarding high incidents of mucormycosis in COVID 2019 positive subjects. In the present paper, we identified and correlated the virus mediated biochemical alterations as the potential ideal environment for propagation of mucorales; and thus concentrate on early diagnosis and treatment of mucormycosis in COVID 2019 cases.

摘要

2019 年冠状病毒病(COVID-19)由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起,是一种可怕的传染病,直接或间接地影响着每个人,是目前最重大的医疗紧急事件之一。COVID-19 是一种多系统疾病,可导致严重的免疫抑制。最初被认为主要影响呼吸系统,它会影响所有重要的器官系统,并导致心血管系统、呼吸系统和胃肠道系统等方面的缺陷,从而导致大量的生化改变。有报道称存在血栓栓塞、铁蛋白水平升高、淋巴细胞减少症、血小板减少症、乳酸酸中毒、类似急性糖尿病状态和细胞因子风暴。关于中性粒细胞水平的数据尚无定论。此外,COVID-19 阳性患者中曲霉菌病的发生率也有所增加。在本文中,我们确定并关联了病毒介导的生化改变,认为其为毛霉菌属繁殖的理想环境;因此,我们专注于 COVID-19 病例中毛霉菌病的早期诊断和治疗。

相似文献

1
Does COVID 19 generate a milieu for propagation of mucormycosis?
Med Hypotheses. 2021 Jul;152:110613. doi: 10.1016/j.mehy.2021.110613. Epub 2021 May 26.
2
How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
Mycopathologia. 2021 Dec;186(6):877-882. doi: 10.1007/s11046-021-00594-6. Epub 2021 Oct 8.
3
Immunopathology of COVID-19 and its implications in the development of rhino-orbital-cerebral mucormycosis: a major review.
Orbit. 2022 Dec;41(6):670-679. doi: 10.1080/01676830.2022.2099428. Epub 2022 Jul 20.
4
The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19.
Crit Rev Microbiol. 2023 May;49(3):318-333. doi: 10.1080/1040841X.2022.2052795. Epub 2022 Mar 24.
5
COVID-19 and mucormycosis superinfection: the perfect storm.
Infection. 2021 Oct;49(5):833-853. doi: 10.1007/s15010-021-01670-1. Epub 2021 Jul 24.
6
Pulmonary embolism and gastric bleed with disseminated mucormycosis - treading dangerous waters.
Monaldi Arch Chest Dis. 2022 Nov 25;93(3). doi: 10.4081/monaldi.2022.2418.
7
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.
9
COVID-19 associated mucormycosis surge: A review on multi-pathway mechanisms.
Parasite Immunol. 2024 Jan;46(1):e13016. doi: 10.1111/pim.13016. Epub 2023 Oct 17.
10
A systematic review on SARS-CoV-2-associated fungal coinfections.
J Med Virol. 2022 Jan;94(1):99-109. doi: 10.1002/jmv.27358. Epub 2021 Oct 5.

引用本文的文献

1
Invasive Sinusitis Presenting with Orbital Complications in COVID Patients: Is Mucor the Only Cause?
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):55-63. doi: 10.1007/s12070-023-04077-6. Epub 2023 Jul 28.
2
COVID-19-Associated Rhinocerebral Mucormycosis, an Incidental Finding or a Matter of Concern - Mixed-Method Systematic Review.
Infect Drug Resist. 2024 Jan 31;17:387-402. doi: 10.2147/IDR.S445458. eCollection 2024.
3
Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: a comprehensive review.
Front Immunol. 2023 Sep 25;14:1264502. doi: 10.3389/fimmu.2023.1264502. eCollection 2023.
4
Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.
Cureus. 2023 Jun 26;15(6):e41010. doi: 10.7759/cureus.41010. eCollection 2023 Jun.
5
Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics.
Front Immunol. 2023 Apr 21;14:1064459. doi: 10.3389/fimmu.2023.1064459. eCollection 2023.
7
Chronic Invasive Aspergillosis with Fulminant Mucormycosis Sparing Palate in a Post-COVID-19 Patient - A Case Report.
Ann Maxillofac Surg. 2022 Jan-Jun;12(1):102-105. doi: 10.4103/ams.ams_296_21. Epub 2022 Aug 16.
9
Oral Tissue Involvement and Probable Factors in Post-COVID-19 Mucormycosis Patients: A Cross-Sectional Study.
Healthcare (Basel). 2022 May 13;10(5):912. doi: 10.3390/healthcare10050912.
10
COVID-19 and Plethora of Fungal Infections.
Curr Fungal Infect Rep. 2022;16(2):47-54. doi: 10.1007/s12281-022-00432-2. Epub 2022 Apr 9.

本文引用的文献

1
Can COVID-19 cause severe neutropenia?
Clin Case Rep. 2020 Oct 26;8(12):3349-3351. doi: 10.1002/ccr3.3369. eCollection 2020 Dec.
2
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis.
Infection. 2021 Oct;49(5):1055-1060. doi: 10.1007/s15010-020-01561-x. Epub 2020 Dec 17.
3
Coronavirus disease 2019 and the pancreas.
Pancreatology. 2020 Dec;20(8):1567-1575. doi: 10.1016/j.pan.2020.10.035. Epub 2020 Oct 12.
4
Rare and Fatal Gastrointestinal Mucormycosis (Zygomycosis) in a COVID-19 Patient: A Case Report.
Clin Endosc. 2020 Nov;53(6):746-749. doi: 10.5946/ce.2020.180. Epub 2020 Nov 19.
6
SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
Med Hypotheses. 2020 Dec;145:110320. doi: 10.1016/j.mehy.2020.110320. Epub 2020 Sep 30.
7
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment.
Postgrad Med J. 2021 May;97(1147):312-320. doi: 10.1136/postgradmedj-2020-138577. Epub 2020 Sep 25.
8
Mucormycosis with orbital compartment syndrome in a patient with COVID-19.
Am J Emerg Med. 2021 Apr;42:264.e5-264.e8. doi: 10.1016/j.ajem.2020.09.032. Epub 2020 Sep 16.
9
COVID-19 presenting as neutropenic fever.
Ann Hematol. 2020 Aug;99(8):1939-1940. doi: 10.1007/s00277-020-04128-w. Epub 2020 Jun 13.
10
COVID-19 may affect the endocrine pancreas by activating Na/H exchanger 2 and increasing lactate levels.
J Endocrinol Invest. 2020 Aug;43(8):1167-1168. doi: 10.1007/s40618-020-01307-4. Epub 2020 May 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验